pT3N0M0 期胃癌切除患者辅助化疗的应用原理。对 Chen 等人的评论。病理淋巴结阴性的 T3 期胃癌的预后因素及辅助化疗的作用。2023 年，，553。
Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. 2023, , 553.
作者信息
Graziosi Luigina, Natalizi Nicola, Donini Annibale
机构信息
Emergency and General Surgery, "Santa Maria della Misericordia" Hospital, University of Perugia, 06129 Perugia, Italy.
出版信息
J Pers Med. 2023 Jun 9;13(6):974. doi: 10.3390/jpm13060974.
Abstract
I read with great interest the well-written and well-made study by Yi-Fu Chen et al. recently published in the " [...].
摘要
我怀着极大的兴趣阅读了陈义夫等人最近发表在《[...]》上的这篇写得很好且制作精良的研究报告。
相似文献
1
Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. 2023, , 553.
J Pers Med. 2023 Jun 9;13(6):974. doi: 10.3390/jpm13060974.
2
Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on "Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. 2023, , 553".
J Pers Med. 2023 Jun 13;13(6):988. doi: 10.3390/jpm13060988.
3
Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer.
J Pers Med. 2023 Mar 20;13(3):553. doi: 10.3390/jpm13030553.
4
Some Concerns from a Radiological Point of View. Comment on Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone. 2022, , 555.
J Pers Med. 2022 Jun 29;12(7):1061. doi: 10.3390/jpm12071061.
5
Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on "Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. 2022, , 555".
J Pers Med. 2022 Jun 30;12(7):1069. doi: 10.3390/jpm12071069.
6
Clinical overview: adjuvant therapy of gastrointestinal cancer.
Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S4-11. doi: 10.1007/s00280-004-0880-4.
7
Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapy.
Anticancer Res. 2000 Sep-Oct;20(5C):3839-42.
8
Adjuvant Chemotherapy in Node-Negative Advanced Gastric Cancer Patients.
J Oncol. 2022 May 20;2022:2286040. doi: 10.1155/2022/2286040. eCollection 2022.
9
Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Ont Health Technol Assess Ser. 2010;10(23):1-57. Epub 2010 Dec 1.
10
Update of adjuvant chemotherapy for resected gastric cancer.
J Gastric Cancer. 2012 Mar;12(1):3-6. doi: 10.5230/jgc.2012.12.1.3. Epub 2012 Mar 30.
引用本文的文献
1
Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on "Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. 2023, , 553".
J Pers Med. 2023 Jun 13;13(6):988. doi: 10.3390/jpm13060988.
本文引用的文献
1
Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer.
J Pers Med. 2023 Mar 20;13(3):553. doi: 10.3390/jpm13030553.
2
Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy.
JAMA Netw Open. 2022 Apr 1;5(4):e225557. doi: 10.1001/jamanetworkopen.2022.5557.
3
Adjuvant chemotherapy indications for stage I gastric cancer patients with negative lymph node.
Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101634. doi: 10.1016/j.clinre.2021.101634. Epub 2021 Mar 1.
4
Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.
Clin Cancer Res. 2017 Aug 1;23(15):4441-4449. doi: 10.1158/1078-0432.CCR-16-2211.
5
Global cancer statistics, 2012.
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
6
Gastric cancer.
Lancet. 2003 Jul 26;362(9380):305-15. doi: 10.1016/s0140-6736(03)13975-x.
Zotero 插件